The ISCRM Fellows program began in 2017, the year the Washington State Legislature first included…
dcorriganAugust 5, 2022
Fred Hutchinson Cancer Center will give the 2022 honorary Hutch Award® to Dr. Anthony S.…
dcorriganAugust 5, 2022
In rodent models of type 2 diabetes (T2D), central administration of fibroblast growth factor 1…
dcorriganAugust 5, 2022
Despite recent therapeutic progress, advanced melanoma remains lethal for many patients. The composition of the…
dcorriganAugust 4, 2022
The Seattle Flu Study (SFS) and Greater Seattle Coronavirus Assessment Network Study (SCAN) are ending…
dcorriganAugust 4, 2022
Immunotherapy drugs called checkpoint inhibitors have given many lung cancer patients a lifesaving new option.…
dcorriganAugust 3, 2022
For children battling through a diagnosis of relapsed leukemia, moving away from standard chemotherapy and…
dcorriganAugust 3, 2022
Seattle-based Precision Oncology company SEngine Precision Medicine has now raised a total of $19M, following…
dcorriganAugust 3, 2022
More than 2 years in the making, a massive bill that Congress completed this week…
dcorriganAugust 3, 2022
